CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.3% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Feb 24, 14:35

Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Mixed Long Term Returns

Novavax Inc
Webhose 2026 Feb 23, 10:38

Jupiter Asset Management Ltd. Sells 779,802 Shares of Novavax, Inc. $NVAX

Novavax Inc
Webhose 2026 Feb 22, 06:15

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Brokerages

Novavax Inc
Webhose 2026 Feb 19, 13:00

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Novavax Inc
Webhose 2026 Feb 18, 03:40

Novavax (NASDAQ:NVAX) Stock Passes Above 200 Day Moving Average - Time to Sell? - Daily Political

Novavax Inc
Webhose 2026 Feb 17, 05:12

Novavax (NASDAQ:NVAX) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?

Novavax Inc
Webhose 2026 Feb 14, 07:09

Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Partnership Shifts

Novavax Inc
Webhose 2026 Feb 14, 03:31

Novavax (NVAX) Is Up 5.5% After Easing Inflation Boosts Interest In Protein-Based Vaccines

Novavax Inc
Webhose 2026 Feb 02, 23:23

Pfizer Reshapes Portfolio With Metsera Deal Novavax Pact And R&D Push - Simply Wall St News

Novavax Inc
Webhose 2026 Feb 01, 10:44

Novavax (NASDAQ:NVAX) Downgraded to "Sell" Rating by Wall Street Zen - Markets Daily

Novavax Inc
Webhose 2026 Jan 31, 05:09

Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts

Novavax Inc
Webhose 2026 Jan 28, 08:51

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts

Novavax Inc

Novavax news

Latest news

Show more

Info

Spread

0.07

Spread (%)

0.7431 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1520990464

Shares Outstanding

162498995

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

2.01

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Trustpilot